Literature DB >> 8604318

Multiple mechanisms may contribute to the cellular anti-adhesive effects of phosphorothioate oligodeoxynucleotides.

Z Khaled1, L Benimetskaya, R Zeltser, T Khan, H W Sharma, R Narayanan, C A Stein.   

Abstract

Phosphorothioate oligodeoxynucleotides complementary to the p65 (Rel A) subunit of the NF-kappaB nuclear transcriptional regulatory factor have been suggested to be sequence specific blockers of cellular adhesion. We studied the effects of Rel A antisense, Rel A sense and other phosphorothioate oligodeoxynucleotides on cellular adhesion and found that blockade of adhesion was predominately non-sequence specific. Phosphorothioate oligodeoxynucleotides bind to the extracellular matrix (ECM) of NIH 3T3 cells, and to the ECM elements laminin and fibronectin. By use of a gel mobility shift assay, the association of the A subunit of laminin with a probe 12mer phosphodiester oligodeoxynucleotide could be demonstrated. This interaction was described by a single-site binding equation (K d = 14 microM). Human Rel A antisense and sense oligodeoxynucleotides, and two synthetic persulfated heparin analogs were excellent competitors of the binding of the probe oligodeoxynucleotide to laminin. Taken together, these data indicate that oligodeoxynucleotide binding occurred at or near the heparin-binding site. Competition for 5' 32p- SdT18 (an 18mer phosphorothioate homopolymer of thymidine) binding to fibronectin with the discrete heparin analogs, as well as with SdC28, was also observed. Phosphorothioate oligodeoxynucleotides (Rel A antisense >> Rel A sense) inhibited the binding of laminin to bovine brain sulfatide, but not to its cell surface receptors on MCF-7 cells. By flow cytometric analysis we have also shown, in contrast to what was observed with laminin, that phosphorothioates a non-specifically block the specific binding of fluoresceinated fibronectin to its cell surface receptors on phorbol-12,13-myristate acetate treated Jurkat cells. Blockade of specific binding occurred in the oligodeoxynucleotide treated cells in the presence or absence of oligomer in the media.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8604318      PMCID: PMC145673          DOI: 10.1093/nar/24.4.737

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  32 in total

Review 1.  Laminins and other strange proteins.

Authors:  J Engel
Journal:  Biochemistry       Date:  1992-11-10       Impact factor: 3.162

2.  Analysis of cDNA for human erythrocyte ankyrin indicates a repeated structure with homology to tissue-differentiation and cell-cycle control proteins.

Authors:  S E Lux; K M John; V Bennett
Journal:  Nature       Date:  1990-03-01       Impact factor: 49.962

3.  Adhesion to laminin and expression of laminin in clonally related transformed and control sublines from an alveolar epithelial cell strain.

Authors:  J G Steele; T A Savolainen; B A Dalton; L Smith; G J Smith
Journal:  Cancer Res       Date:  1990-06-01       Impact factor: 12.701

4.  Suramin inhibits laminin- and thrombospondin-mediated melanoma cell adhesion and migration and binding of these adhesive proteins to sulfatide.

Authors:  V S Zabrenetzky; E C Kohn; D D Roberts
Journal:  Cancer Res       Date:  1990-09-15       Impact factor: 12.701

Review 5.  Nucleotide and oligonucleotide derivatives as enzyme and nucleic acid targeted irreversible inhibitors. Chemical aspects.

Authors:  D G Knorre; V V Vlassov; V F Zarytova; G G Karpova
Journal:  Adv Enzyme Regul       Date:  1985

6.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

7.  An NF kappa B-like factor is essential but not sufficient for cytokine induction of endothelial leukocyte adhesion molecule 1 (ELAM-1) gene transcription.

Authors:  J Whelan; P Ghersa; R Hooft van Huijsduijnen; J Gray; G Chandra; F Talabot; J F DeLamarter
Journal:  Nucleic Acids Res       Date:  1991-05-25       Impact factor: 16.971

8.  Monovalent cation induced structural transitions in telomeric DNAs: G-DNA folding intermediates.

Authors:  C C Hardin; E Henderson; T Watson; J K Prosser
Journal:  Biochemistry       Date:  1991-05-07       Impact factor: 3.162

9.  Inhibition of cell adhesion to plastic substratum by phosphorothioate oligonucleotide.

Authors:  P H Watson; R T Pon; R P Shiu
Journal:  Exp Cell Res       Date:  1992-10       Impact factor: 3.905

10.  Effects of suramin-related and other clinically therapeutic polyanions on protein kinase C activity.

Authors:  Z Khaled; D Rideout; K R O'Driscoll; D Petrylak; A Cacace; R Patel; L C Chiang; S Rotenberg; C A Stein
Journal:  Clin Cancer Res       Date:  1995-01       Impact factor: 12.531

View more
  11 in total

1.  The experimental use of antisense oligonucleotides: a guide for the perplexed.

Authors:  C A Stein
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

Review 2.  Leukocyte-endothelial cell adhesion: avenues for therapeutic intervention.

Authors:  J Panés; M Perry; D N Granger
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

Review 3.  Specific VDAC inhibitors: phosphorothioate oligonucleotides.

Authors:  C A Stein; Marco Colombini
Journal:  J Bioenerg Biomembr       Date:  2008-06       Impact factor: 2.945

4.  Formation of a G-tetrad and higher order structures correlates with biological activity of the RelA (NF-kappaB p65) 'antisense' oligodeoxynucleotide.

Authors:  L Benimetskaya; M Berton; A Kolbanovsky; S Benimetsky; C A Stein
Journal:  Nucleic Acids Res       Date:  1997-07-01       Impact factor: 16.971

5.  Antisense Oligonucleotides: Treatment Strategies and Cellular Internalization.

Authors:  Colton M Miller; Edward N Harris
Journal:  RNA Dis       Date:  2016-08-15

6.  Sequence-independent inhibition of in vitro vascular smooth muscle cell proliferation, migration, and in vivo neointimal formation by phosphorothioate oligodeoxynucleotides.

Authors:  W Wang; H J Chen; A Schwartz; P J Cannon; C A Stein; L E Rabbani
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

7.  Fully phosphorothioate-modified CpG ODN with PolyG motif inhibits the adhesion of B16 melanoma cells in vitro and tumorigenesis in vivo.

Authors:  Xueju Wang; Liying Wang; Min Wan; Xiuli Wu; Yongli Yu; Liping Wang
Journal:  Nucleic Acid Ther       Date:  2013-07-13       Impact factor: 5.486

8.  Inhibitory effect of ribbon-type NF-kappaB decoy oligodeoxynucleotides on osteoclast induction and activity in vitro and in vivo.

Authors:  Yasuo Kunugiza; Tetsuya Tomita; Naruya Tomita; Ryuichi Morishita; Hideki Yoshikawa
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

9.  relA over-expression reduces tumorigenicity and activates apoptosis in human cancer cells.

Authors:  A Ricca; A Biroccio; D Trisciuoglio; M Cippitelli; G Zupi; D Del Bufalo
Journal:  Br J Cancer       Date:  2001-12-14       Impact factor: 7.640

10.  Electronic Structures of LNA Phosphorothioate Oligonucleotides.

Authors:  Henrik G Bohr; Irene Shim; Cy Stein; Henrik Ørum; Henrik F Hansen; Troels Koch
Journal:  Mol Ther Nucleic Acids       Date:  2017-06-01       Impact factor: 8.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.